Immediate Impact

3 from Science/Nature 68 standout
Sub-graph 1 of 24

Citing Papers

Glioblastoma Therapy: Past, Present and Future
2024 Standout
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout

Works of Mona El-Hashimy being referenced

Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study
2020
Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer
2012

Author Peers

Author Last Decade Papers Cites
Mona El-Hashimy 243 272 342 18 692
R Pingitore 200 263 221 26 688
Wookyeom Yang 119 252 303 25 770
Miia Suuriniemi 159 230 195 18 828
Hernan G. Vasquez 178 313 213 15 784
Daniel Navarro 203 292 277 19 628
Frédéric Commo 220 242 267 16 760
Valentina Rossi 132 390 235 25 752
Natasha Musrap 152 276 161 14 595
Stina Häggström Rudolfsson 334 313 178 22 767
Virgil Gadaleanu 267 309 164 24 808

All Works

Loading papers...

Rankless by CCL
2026